在他们的声音:肯尼亚妇女的经验与癌症治疗相关的副作用
Tayreez Mushani1, Dinah Kassaman1, Sharon Brownie2,3,4
1School of Nursing and Midwifery, Aga Khan University, Nairobi, Kenya.
Asia-Pacific journal of oncology nursing
|July 25, 2024
概括
管理癌症治疗副作用的肯尼亚妇女发现信仰和事先的信息有帮助. 改善患者教育和资源对于在癌症治疗期间获得更好的护理和支持至关重要.
科学领域:
- 在瘤学瘤学.
- 质量健康研究 质量健康研究
- 患者体验 患者体验
背景情况:
- 癌症治疗往往会导致严重的副作用,影响患者的生活质量.
- 有效管理与治疗相关的副作用对于患者的坚持和健康至关重要.
研究的目的:
- 探索肯尼亚妇女在处理乳腺癌和宫癌治疗副作用方面的经验.
- 确定以患者为中心的策略,以改善副作用管理和患者教育.
主要方法:
- 一项定性研究的二次分析,涉及对接受癌症治疗的妇女进行深入采访.
- 使用NVivo软件对采访数据进行有目的的抽样和主题分析.
主要成果:
- 主要的副作用包括疲劳,脱发,皮肤/指甲变化,恶心和吐.
- 接受治疗前信息的女性报告了更好的副作用管理.
- 副作用影响了日常生活和身体形象;信仰提供了安慰.
结论:
- 患者的经验强调了需要加强卫生资源和可访问的教育材料的需要.
- 需要区域相关的战略来支持肯尼亚妇女管理癌症治疗副作用.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Disorders of the Female Reproductive System
344
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
344
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
190
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
190


